Efficacy of concurrent chemoradiotherapy for patients with limited-disease small-cell lung cancer: a retrospective, nationwide, population-based cohort study

BACKGROUND: Small-cell lung cancer (SCLC) is a highly proliferative, rapidly growing tumor with a poor prognosis, even in cases of limited disease (LD). Timely and accurate high-intensity therapy is necessary. For concurrent chemoradiotherapy (CCRT), etoposide/platinum (EP)-based regimens are recomm...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo Ree, Hong, Ji Hyung, Sung, Soo-Yoon, Kim, Yeo Hyung, Chun, Sang Hoon, Lee, Hyun Woo, Lee, Jung Soo, Ko, Yoon Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011172/
https://www.ncbi.nlm.nih.gov/pubmed/33789628
http://dx.doi.org/10.1186/s12885-021-08082-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8011172/
https://www.ncbi.nlm.nih.gov/pubmed/33789628
http://dx.doi.org/10.1186/s12885-021-08082-2

Ejemplares similares